cancerfacts.com - log on. fight back.  
General Services
Cancer News
  Personal Stories
  Support Groups
  Links and Resources
Help Center
  Help
  Contact Us
  Suggestion Box
About Us
  About cancerfacts.com
  cancerfacts.com
    in the News
  Visitor Comments







Radiotherapy-related fatigue may result from inflammation
Source: (cancerfacts.com
Thursday, August 20, 2009


PHILADELPHIA – Aug. 20, 2009 – Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the network of cells and proteins, called cytokines, involved in producing an inflammatory response, say researchers.

Led by Dr. Julie Bower, an associate professor in the Department of Psychology and Psychiatry at UCLA, the researchers conducted a study of 28 patients with breast cancer and 20 patients with prostate cancer. All participants had early stage cancers. Patients completed questionnaires and provided blood samples so researchers could determine the level of blood components markers of inflammation. Their study is reported in the Aug. 15 issue of Clinical Cancer Research.

"This study suggests that exposure to radiation is releasing these inflammatory cytokines and that may be contributing to fatigue," said Bower in a prepared statement.

As expected, there was a strong link between radiotherapy treatment and fatigue. In a new finding, however, the researchers noted that increases in serum markers of cytokine activity involved in an immune response were also linked with fatigue.

Scientists have been studying the role of inflammation in several diseases and have recently made breakthroughs about the link between inflammation and diseases like heart disease, Alzheimer's and cancer. There is growing evidence that inflammation may also contribute to depression and other behavioral disturbances, including fatigue and sleep problems.

Dr. Stephen Hahn, chair of the Department of Radiation Oncology at the Abramson Cancer Center at the University of Pennsylvania, said this study is an important step forward in understanding the biological basis for fatigue.

"Fatigue related to radiotherapy is very common but we do not have any good idea about why it occurs. This suggests one possible mechanism and suggests an avenue for treatment," said Hahn, who is also an editorial board member of Clinical Cancer Research.

SOURCE: adapted from press materials provided by the American Association for Cancer Research.

Copyright © 2002, 2003, 2004, 2005, 2006, 2007, 2008 NexCura, Inc. All rights reserved. Republication or redistribution of cancerfacts.com content, including by framing or similar means, is expressly prohibited without the prior written consent of NexCura. NexCura® is a registered trademark and cancerfacts.com™ is a trademark of NexCura, Inc. or its affiliates. Copyright © 2003, 2004, 2005 2006, 2007, 2008, 2009. All rights reserved. This information is for educational purposes only.








Top


Powered By Nexcura

   Terms and Conditions
   Privacy Statement
   Trademark and Copyright


  search by keyword




GO

Advanced Search


Aspirin use after colorectal cancer boosts survival

Aspirin may increase prostate cancer survival

Aspirin or ibuprofen prevents breast cancer

Aspirin may boost cancer therapy






Bladder
Breast
Cervical
Colorectal
Head and Neck
Hodgkin Lymphoma
Kidney
Leukemia - Adult ALL
Leukemia - Adult AML
Leukemia - Adult CML
Lung - Non-Small Cell
Lung - Small Cell
Melanoma
Multiple Myeloma
Non-Hodgkin's Lymphoma
Ovarian
Pancreatic
Prostate
Testicular
Uterine



HON Logo
We subscribe to the
HONcode principles
of the
Health On the Net
Foundation






HOME | CONTACT US | SUGGESTION BOX


cancerfacts.com, the cancerfacts.com logo, NexProfiler, NexCura, Heart Profiler, the NexProfiler logo, the NexCura logo, the Heart Profiler logo and the Powered by NexCura logo are either trademarks or registered trademarks of NexCura, Inc. Copyright © NexCura, Inc. All rights reserved. U.S. Patent No. 6,581,038 & Patents Pending. Other foreign patents may apply. This information is for educational purposes only.